遗传性视网膜病变临床试验招募信息（全球在招）
这里汇总了全球正在招募患者的 遗传性视网膜病变（国际通用名 inherited retinal disease）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖视网膜色素变性等说法。
正在招募的遗传性视网膜病变新药试验
Safety and Efficacy of ZVS203e in the Treatment of Retinitis Pigmentosa Caused by RHO Gene Mutation
I 期 / II 期招募中中国NCT06952842Impact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients
不适用招募中中国NCT07126470Longitudinal Prospective Natural History Study of Retinopathy in Zellweger Spectrum Disorder
不适用招募中美国加拿大NCT06190626Safety, PK and PD of FLQ-101 in Premature Neonates
I 期招募中美国NCT07093255Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma
早期 I 期招募中中国NCT06424301Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy
不适用招募中中国NCT06717412Rod and Cone Mediated Function in Retinal Disease
不适用招募中美国NCT02617966A Clinical Trial Evaluating the Safety and Efficacy of a New Light Combination Therapy Addressing Intermediate AMD
不适用招募中意大利NCT06557369Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies
I 期 / II 期招募中EgyptNCT06787482Characterizing the Retinal Microvasculature in Patients with Fabry Disease: a Prospective Observational Study
不适用招募中德国NCT06758648A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
不适用招募中美国NCT07425574A Study of LX107 Gene Therapy in AIPL1-IRD Patients
早期 I 期招募中中国NCT07063030
遗传性视网膜病变试验不在中国大陆，还能参加吗？
可以尝试四条现实路径：查找国内同类试验、申请同情用药与扩展准入、赴境外研究中心入组、直接写信给申办方申请在华开展。本站提供中英文对照的咨询信模板，患者和家属填写基本情况即可生成。